These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Immediate vesicular eruption caused by topical 23% lidocaine 7% tetracaine ointment in a patient scheduled for laser therapy: a new adverse drug reaction. Vij A; Markus R J Cosmet Dermatol; 2011 Dec; 10(4):307-10. PubMed ID: 22151940 [TBL] [Abstract][Full Text] [Related]
8. Aerosol-OT microemulsions as transdermal carriers of tetracaine hydrochloride. Changez M; Varshney M Drug Dev Ind Pharm; 2000 May; 26(5):507-12. PubMed ID: 10789062 [TBL] [Abstract][Full Text] [Related]
9. Contact dermatitis and bradycardia in a preterm infant given tetracaine 4% gel. Taddio A; Lee CM; Parvez B; Koren G; Shah V Ther Drug Monit; 2006 Jun; 28(3):291-4. PubMed ID: 16778708 [TBL] [Abstract][Full Text] [Related]
10. Intrathecal hyperbaric 0.5% tetracaine as a possible cause of transient neurologic toxicity. Sumi M; Sakura S; Kosaka Y Anesth Analg; 1996 May; 82(5):1076-7. PubMed ID: 8610872 [No Abstract] [Full Text] [Related]
11. Cooling tetracaine to reduce pain of instillation before surgery. Soltani AE; Ganji M; Goodarzi M; Moghimi S Eye (Lond); 2009 Jun; 23(6):1470. PubMed ID: 19373261 [No Abstract] [Full Text] [Related]
13. Fibrinous Anterior Uveitis Following Topical Tetracaine Abuse. Makri OE; Plotas P; Tsapardoni F; Georgalas I; Georgakopoulos CD Curr Drug Saf; 2017; 12(3):216-218. PubMed ID: 28521706 [TBL] [Abstract][Full Text] [Related]
14. [Tetracaine-induced systemic contact-type dermatitis]. Huerta Brogeras M; Avilés JA; González-Carrascosa M; de la Cueva P; Suárez R; Lázaro P Allergol Immunopathol (Madr); 2005; 33(2):112-4. PubMed ID: 15808119 [TBL] [Abstract][Full Text] [Related]
15. An Observational Study to Determine Whether Routinely Sending Patients Home With a 24-Hour Supply of Topical Tetracaine From the Emergency Department for Simple Corneal Abrasion Pain Is Potentially Safe. Waldman N; Winrow B; Densie I; Gray A; McMaster S; Giddings G; Meanley J Ann Emerg Med; 2018 Jun; 71(6):767-778. PubMed ID: 28483289 [TBL] [Abstract][Full Text] [Related]
16. A risk-benefit assessment of topical percutaneous local anaesthetics in children. Russell SC; Doyle E Drug Saf; 1997 Apr; 16(4):279-87. PubMed ID: 9113495 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the depth and duration of anesthesia from heated lidocaine/tetracaine (Synera) patches compared with placebo patches applied to healthy adult volunteers. Wallace MS; Kopecky EA; Ma T; Brophy F; Campbell JC Reg Anesth Pain Med; 2010; 35(6):507-13. PubMed ID: 20975464 [TBL] [Abstract][Full Text] [Related]
18. Topical anesthetic-induced methemoglobinemia: a case report and review of the literature. Vessely MB; Zitsch RP Otolaryngol Head Neck Surg; 1993 Jun; 108(6):763-7. PubMed ID: 8516018 [No Abstract] [Full Text] [Related]
19. [Use of 2% anilocaine solution for injections in ophthalmology]. Goriachev IuE; Veretennikova LG; Sobianin NA; Pantsurkln VI Vestn Oftalmol; 2003; 119(5):48-9. PubMed ID: 14598499 [No Abstract] [Full Text] [Related]